United States securities and exchange commission logo





                          May 30, 2023

       Marvin Slosman
       Chief Executive Officer
       InspireMD, Inc.
       4 Menorat Hamaor. St.
       Tel Aviv, Israel 6744832

                                                        Re: InspireMD, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed May 23, 2023
                                                            File No. 333-272149

       Dear Marvin Slosman:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Margaret
Schwartz at 202-551-7153 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Industrial Applications and

                          Services
       cc:                                              Gary Emmanuel, Esq.